# pecan biotherapeutics, Inc — Form D

pecan biotherapeutics, Inc of Dallas, TX, a company, filed a Form D exempt-offering notice with the SEC on 2009-10-30. The offering totals $250K, of which $250K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2009-10-30
- Form: D
- Accession: 0001451233-09-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $250K
- Amount sold: $250K
- Minimum investment: $250K
- Investors: 1
- Date of first sale: 2009-08-28
- Revenue range: No Revenues
- SEC file number: 021-124899

## Issuer

- Name: pecan biotherapeutics, Inc
- CIK: 0001451233
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 3811 Turtle Creek Blvd., Dallas, TX, 75219
- Phone: 214-543-3175

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| MICHAEL BANIGAN | Director | RENO, NV |
| Joel Fineberg | Director | Dallas, TX |
| Steve Malouf | Director | Dallas, TX |
| Craig Rosenfeld | Director | Dallas, TX |
| Craig Rosenfeld | Executive Officer | Dallas, TX |

## More

- [CIK 1451233 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1451233&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001451233-09-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.